A Case of Luscan-Lumish Syndrome: Possible Involvement of Enhanced GH Signaling
- 29 November 2020
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (3) , 718-723
Abstract
Context Luscan-Lumish syndrome (LLS) is characterized by postnatal overgrowth, obesity, Chiari I malformation, seizures, and intellectual disability. SET domain-containing protein 2 (SETD2) is a histone methyltransferase, where mutations in the gene are associated with the development of LLS. However, mechanisms underlying LLS remain unclear. Case description A 20-year-old man was referred to our hospital because of tall stature. His body height was 188.2 cm (+3.18 SD) and he showed obesity with a body mass index of 28.4 kg/m 2. He exhibited acral overgrowth, jaw malocclusion, and prognathism, but no history of seizures, intellectual disability, or speech delay. Serum growth hormone (GH), insulin-like growth factor 1 (IGF-1), and nadir GH levels after administration of 75 g oral glucose were within normal range. Pituitary magnetic resonance imaging showed no pituitary adenoma, but Chiari I malformation. Whole exome sequencing analysis of the proband revealed a de novo heterozygous germline mutation in SETD2 (c.236T>A, p.L79H). Skin fibroblasts derived from the patient grew faster than those from his father and the control subject. In addition, these cells showed enhanced tyrosine phosphorylation and transcriptional activity of signal transducer and activator of transcription 5b (STAT5b) and increased IGF-1 expression induced by GH. Conclusion This is a mild case of LLS with a novel mutation in SETD2 without neurological symptoms. LLS should be differentiated in a patient with gigantism without pituitary tumors. Although further investigation is necessary, this is the first study to suggest the involvement of aberrant GH signaling in the development of LLS.Keywords
Funding Information
- Japan Society for the Promotion of Science (23659477, 26670459, 17K16164)
- Japan Agency for Medical Research and Development (17bm0804012h0001)
- Uehara Memorial Foundation
- Naito Foundation
This publication has 9 references indexed in Scilit:
- DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2 ‐DMR0 as a DNA methylation‐dependent, P0 promoter‐specific enhancerThe FASEB Journal, 2019
- A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel SequencingMolecular Syndromology, 2018
- Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genesNucleic Acids Research, 2015
- Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and EpilepsyJournal of Autism and Developmental Disorders, 2015
- Understanding the language of Lys36 methylation at histone H3Nature Reviews Molecular Cell Biology, 2012
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodelingProceedings of the National Academy of Sciences, 2010
- Gigantism in mice lacking suppressor of cytokine signalling-2Nature, 2000
- Huntingtin interacts with a family of WW domain proteinsHuman Molecular Genetics, 1998